For Oncology Nurses: Bispecific Antibodies in Multiple Myeloma — An Interview with Dr Tiffany A Richards
Research To Practice | Oncology Videos · Dr. Neil Love
March 24, 20251h 5m
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring an interview with Dr Tiffany A Richards, including the following topics:
- Current treatment landscape for multiple myeloma (MM) (0:00)
- CAR (chimeric antigen receptor) T-cell therapy for the management of MM (10:22)
- Bispecific antibodies for relapsed/refractory MM (24:26)
- Case: A woman in her early 80s with relapsed MM receives teclistamab (35:56)
- Case: A man in his early 70s with multiregimen-refractory MM receives linvoseltamab on a clinical trial (44:06)
- Case: A woman in her early 60s with relapsed MM and extramedullary disease receives talquetamab (48:38)
- Role of nurses in transitions of care for patients with MM (53:15)
- Case: A man in his mid 70s with heavily pretreated MM experiences a response to teclistamab (58:56)
- Risk of second cancers with bispecific antibodies and other immunotherapy-based treatment approaches (1:00:55)